SEARCH

SEARCH BY CITATION

References

  • Abramowski D., Rabe S., Upadhaya A. R. et al. (2012) Transgenic expression of intraneuronal Abeta42 but not Abeta40 leads to cellular Abeta lesions, degeneration, and functional impairment without typical Alzheimer's disease pathology. J. Neurosci. 32, 12731283.
  • Arancio O., Lev-Ram V., Tsien R. Y., Kandel E. R. and Hawkins R. D. (1996) Nitric oxide acts as a retrograde messenger during long-term potentiation in cultured hippocampal neurons. J. Physiol. Paris 90, 321322.
  • Austin S. A., Santhanam A. V. and Katusic Z. S. (2010) Endothelial nitric oxide modulates expression and processing of amyloid precursor protein. Circ. Res. 107, 14981502.
  • Austin S. A., d'Uscio L. V. and Katusic Z. S. (2012) Supplementation of nitric oxide attenuates AbetaPP and BACE1 protein in cerebral microcirculation of eNOS-deficient mice. J. Alzheimers Dis. 33, 2933.
  • Berendji-Grun D., Kolb-Bachofen V. and Kroncke K. D. (2001) Nitric oxide inhibits endothelial IL-1[beta]-induced ICAM-1 gene expression at the transcriptional level decreasing Sp1 and AP-1 activity. Mol. Med. 7, 748754.
  • Busciglio J., Lorenzo A. and Yankner B. A. (1992) Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol. Aging 13, 609612.
  • Chambon C., Wegener N., Gravius A. and Danysz W. (2011) Behavioural and cellular effects of exogenous amyloid-beta peptides in rodents. Behav. Brain Res. 225, 623641.
  • Colton C. A., Wilcock D. M., Wink D. A., Davis J., Van Nostrand W. E. and Vitek M. P. (2008) The effects of NOS2 gene deletion on mice expressing mutated human AbetaPP. J. Alzheimers Dis. 15, 571587.
  • Dere E., Frisch C., De Souza Silva M. A., Godecke A., Schrader J. and Huston J. P. (2001) Unaltered radial maze performance and brain acetylcholine of the endothelial nitric oxide synthase knockout mouse. Neuroscience 107, 561570.
  • Dere E., De Souza Silva M. A., Topic B., Fiorillo C., Li J. S., Sadile A. G., Frisch C. and Huston J. P. (2002) Aged endothelial nitric oxide synthase knockout mice exhibit higher mortality concomitant with impaired open-field habituation and alterations in forebrain neurotransmitter levels. Genes Brain Behav. 1, 204213.
  • Domek-Lopacinska K. U. and Strosznajder J. B. (2010) Cyclic GMP and nitric oxide synthase in aging and Alzheimer's disease. Mol. Neurobiol. 41, 129137.
  • Dore S., Kar S. and Quirion R. (1997) Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proc. Natl Acad. Sci. USA 94, 47724777.
  • Dubreuil D., Tixier C., Dutrieux G. and Edeline J. M. (2003) Does the radial arm maze necessarily test spatial memory? Neurobiol. Learn. Mem. 79, 109117.
  • Dudzinski D. M., Igarashi J., Greif D. and Michel T. (2006) The regulation and pharmacology of endothelial nitric oxide synthase. Annu. Rev. Pharmacol. Toxicol. 46, 235276.
  • Dyrks T., Dyrks E., Masters C. L. and Beyreuther K. (1993) Amyloidogenicity of rodent and human beta A4 sequences. FEBS Lett. 324, 231236.
  • Faraci F. M. (2011) Protecting against vascular disease in brain. Am. J. Physiol. Heart Circ. Physiol. 300, H1566H1582.
  • Frisch C., Dere E., Silva M. A., Godecke A., Schrader J. and Huston J. P. (2000) Superior water maze performance and increase in fear-related behavior in the endothelial nitric oxide synthase-deficient mouse together with monoamine changes in cerebellum and ventral striatum. J. Neurosci. 20, 66946700.
  • Garthwaite G., Bartus K., Malcolm D., Goodwin D., Kollb-Sielecka M., Dooldeniya C. and Garthwaite J. (2006) Signaling from blood vessels to CNS axons through nitric oxide. J. Neurosci. 26, 77307740.
  • Godecke A., Decking U. K., Ding Z., Hirchenhain J., Bidmon H. J., Godecke S. and Schrader J. (1998) Coronary hemodynamics in endothelial NO synthase knockout mice. Circ. Res. 82, 186194.
  • Gutsaeva D. R., Carraway M. S., Suliman H. B., Demchenko I. T., Shitara H., Yonekawa H. and Piantadosi C. A. (2008) Transient hypoxia stimulates mitochondrial biogenesis in brain subcortex by a neuronal nitric oxide synthase-dependent mechanism. J. Neurosci. 28, 20152024.
  • Hoffman P. W. and Chernak J. M. (1995) DNA binding and regulatory effects of transcription factors SP1 and USF at the rat amyloid precursor protein gene promoter. Nucleic Acids Res. 23, 22292235.
  • Hongo F., Garban H., Huerta-Yepez S., Vega M., Jazirehi A. R., Mizutani Y., Miki T. and Bonavida B. (2005) Inhibition of the transcription factor Yin Yang 1 activity by S-nitrosation. Biochem. Biophys. Res. Commun. 336, 692701.
  • Hopper R. A. and Garthwaite J. (2006) Tonic and phasic nitric oxide signals in hippocampal long-term potentiation. J. Neurosci. 26, 1151311521.
  • Hoshi M., Sato M., Matsumoto S., Noguchi A., Yasutake K., Yoshida N. and Sato K. (2003) Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta. Proc. Natl Acad. Sci. USA 100, 63706375.
  • Huang P. L. (2009) eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol. Metab. 20, 295302.
  • Hyman B. T., Van Hoesen G. W., Damasio A. R. and Barnes C. L. (1984) Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 225, 11681170.
  • Iadecola C., Zhang F., Niwa K. et al. (1999) SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat. Neurosci. 2, 157161.
  • Kukull W. A., Higdon R., Bowen J. D., McCormick W. C., Teri L., Schellenberg G. D., van Belle G., Jolley L. and Larson E. B. (2002) Dementia and Alzheimer disease incidence: a prospective cohort study. Arch. Neurol. 59, 17371746.
  • Kummer M. P., Hermes M., Delekarte A. et al. (2011) Nitration of tyrosine 10 critically enhances amyloid beta aggregation and plaque formation. Neuron 71, 833844.
  • Kwak Y. D., Wang R., Li J. J., Zhang Y. W., Xu H. and Liao F. F. (2011) Differential regulation of BACE1 expression by oxidative and nitrosative signals. Mol. Neurodegener. 6, 17.
  • Lahiri D. K., Chen D., Ge Y. W., Farlow M., Kotwal G., Kanthasamy A., Ingram D. K. and Greig N. H. (2003) Does nitric oxide synthase contribute to the pathogenesis of Alzheimer's disease?: effects of beta-amyloid deposition on NOS in transgenic mouse brain with AD pathology. Ann. N. Y. Acad. Sci. 1010, 639642.
  • Li W., Mital S., Ojaimi C., Csiszar A., Kaley G. and Hintze T. H. (2004) Premature death and age-related cardiac dysfunction in male eNOS-knockout mice. J. Mol. Cell. Cardiol. 37, 671680.
  • Lu Y. F., Kandel E. R. and Hawkins R. D. (1999) Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus. J. Neurosci. 19, 1025010261.
  • Martin B. L., Tokheim A. M., McCarthy P. T., Doms B. S., Davis A. A. and Armitage I. M. (2006) Metallothionein-3 and neuronal nitric oxide synthase levels in brains from the Tg2576 mouse model of Alzheimer's disease. Mol. Cell. Biochem. 283, 129137.
  • Nathan C., Calingasan N., Nezezon J. et al. (2005) Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase. J. Exp. Med. 202, 11631169.
  • Nimmerjahn A., Kirchhoff F. and Helmchen F. (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 13141318.
  • Niwa K., Kazama K., Younkin L., Younkin S. G., Carlson G. A. and Iadecola C. (2002) Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am. J. Physiol. Heart Circ. Physiol. 283, H315H323.
  • O'Keefe J. and Dostrovsky J. (1971) The hippocampus as a spatial map. Preliminary evidence from unit activity in the freely-moving rat. Brain Res. 34, 171175.
  • Pak T., Cadet P., Mantione K. J. and Stefano G. B. (2005) Morphine via nitric oxide modulates beta-amyloid metabolism: a novel protective mechanism for Alzheimer's disease. Med. Sci. Monit. 11, BR357BR366.
  • Peng H. B., Libby P. and Liao J. K. (1995) Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J. Biol. Chem. 270, 1421414219.
  • Puzzo D., Staniszewski A., Deng S. X. et al. (2009) Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an Alzheimer's disease mouse model. J. Neurosci. 29, 80758086.
  • Reneerkens O. A., Rutten K., Steinbusch H. W., Blokland A. and Prickaerts J. (2009) Selective phosphodiesterase inhibitors: a promising target for cognition enhancement. Psychopharmacology 202, 419443.
  • Sambamurti K., Kinsey R., Maloney B., Ge Y. W. and Lahiri D. K. (2004) Gene structure and organization of the human beta-secretase (BACE) promoter. FASEB J. 18, 10341036.
  • Simic G., Lucassen P. J., Krsnik Z., Kruslin B., Kostovic I., Winblad B. and Bogdanovi, (2000) nNOS expression in reactive astrocytes correlates with increased cell death related DNA damage in the hippocampus and entorhinal cortex in Alzheimer's disease. Exp. Neurol. 165, 1226.
  • Thatcher G. R., Bennett B. M., Dringenberg H. C. and Reynolds J. N. (2004) Novel nitrates as NO mimetics directed at Alzheimer's disease. J. Alzheimers Dis. 6, S75S84.
  • de la Torre J. C. (1997) Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging. Gerontology 43, 2643.
  • Vasilevko V., Passos G. F., Quiring D., Head E., Kim R. C., Fisher M. and Cribbs D. H. (2010) Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy. Ann. N. Y. Acad. Sci. 1207, 5870.
  • Viet M. H. and Li M. S. (2012) Amyloid peptide Abeta40 inhibits aggregation of Abeta42: evidence from molecular dynamics simulations. J. Chem. Phys. 136, 245105.
  • Yankner B. A., Duffy L. K. and Kirschner D. A. (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250, 279282.
  • Zou K., Gong J. S., Yanagisawa K. and Michikawa M. (2002) A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage. J. Neurosci. 22, 48334841.
  • Zou K., Kim D., Kakio A. et al. (2003) Amyloid beta-protein (Abeta)1-40 protects neurons from damage induced by Abeta1-42 in culture and in rat brain. J. Neurochem. 87, 609619.